BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 6447522)

  • 1. Enhancement of antitumor effect of cyclophosphamide by thaliblastine in Lewis lung carcinoma and L1210 leukemia in mice.
    Stoychkov JN; Miloushev AS
    Biomedicine; 1980 Apr; 33(2):42-4. PubMed ID: 6447522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experiment to potentiate the effect of cyclophosphamide combined with tempidon and caffeine in leukemia L1210 and Lewis hepatic carcinoma].
    Stoichkov I; Milushev A; Todorov D
    Eksp Med Morfol; 1978; 17(1):9-14. PubMed ID: 639751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of forphenicinol, a small molecular immunomodifier, in combination with cyclophosphamide on growth of and immunity to syngeneic murine tumors.
    Nitta K; Tanaka T; Takeuchi M
    Cancer Treat Rep; 1985 Mar; 69(3):285-91. PubMed ID: 3978657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined therapy of L1210 leukemia with cyclophosphamide and lycurim.
    Stoychkov JN; Milushev AS; Todorov DK
    Neoplasma; 1980; 27(1):33-6. PubMed ID: 6892839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of amidoximes (hydroxyurea analogs) in murine tumor systems.
    Flora KP; van't Riet B; Wampler GL
    Cancer Res; 1978 May; 38(5):1291-5. PubMed ID: 639062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of dose, schedule, and route of administration on the in vivo toxicity and antitumor activity of two activated sulfhydryl derivatives of cyclophosphamide.
    Ramonas LM; Erickson LC; Ringsdorf H; Zaharko DS
    Cancer Res; 1980 Oct; 40(10):3704-8. PubMed ID: 7438053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adriamycin and cyclophosphamide in combination chemotherapy of L1210 leukemia.
    Avery TL; Roberts D
    Cancer Res; 1977 Mar; 37(3):678-83. PubMed ID: 837368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cimetidine combination with cyclophosphamide in transplanted murine tumors.
    Khandalekar DD; Ganu UK; Gokhale SV
    Indian J Physiol Pharmacol; 1989; 33(3):171-4. PubMed ID: 2592043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effectiveness of combined action of vitamins A, E and C and cyclophosphane or adriamycin on growth of transplanted tumors in mice].
    Mosienko VS; Khasanova LT; Sukolinskiĭ VN; Morozkina TS
    Eksp Onkol; 1990; 12(3):55-7. PubMed ID: 2344827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor activity of pyrimidinones, a class of small-molecule biological response modifiers.
    Li LH; Wallace TL; Wierenga W; Skulnick HI; DeKoning TF
    J Biol Response Mod; 1987 Feb; 6(1):44-55. PubMed ID: 3559628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy of advanced L1210 leukemia with platinum compounds in combination with other antitumor agents.
    Gale GR; Atkins LM; Meischen SJ; Smith AB; Walker EM
    Cancer Treat Rep; 1977; 61(3):445-50. PubMed ID: 872142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potentiation of nitrosoureas using chlorpromazine and caffeine in the treatment of murine tumors.
    Rose WC; Trader MW; Dykes DJ; Laster WR; Schabel FM
    Cancer Treat Rep; 1978 Dec; 62(12):2085-93. PubMed ID: 751716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of thaliblastine on transplantable tumours in mice.
    Mircheva J; Stoychkov J
    Biomedicine; 1976 Sep; 25(8):280-1. PubMed ID: 137002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic action of 2-chlorodeoxyadenosine and cyclophosphamide on murine leukemias L1210 and P388.
    Góra-Tybor J; Robak T
    Acta Haematol Pol; 1993; 24(2):177-82. PubMed ID: 8103959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental approach for the search of effective drug combination in cancer chemotherapy.
    Bello JL; Kariev NI; Mainardi JV; Betancourt M; Lage A; Barroso MC; Alfonso L
    Neoplasma; 1982; 29(1):65-71. PubMed ID: 7070556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity evaluation of bromine-substituted analogues of ifosfamide. I. Stereodifferentiation of biological effects and selection of the most potent compounds.
    Glazman-Kuśnierczyk H; Matuszyk J; Radzikowski C
    Immunopharmacol Immunotoxicol; 1992; 14(4):883-911. PubMed ID: 1294626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumour and antimetastatic effect of genistein alone or combined with cyclophosphamide in mice transplanted with various tumours depends on the route of tumour transplantation.
    Wietrzyk J; Opolski A; Madej J; Radzikowski C
    In Vivo; 2000; 14(2):357-62. PubMed ID: 10836210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic performance of carminomycin-cyclophosphamide against L1210 leukemia.
    Avery TL; Cruze PG
    Cancer Res; 1978 Sep; 38(9):2892-5. PubMed ID: 679196
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of combination chemotherapy of nitrosourea MCNU with various anti-tumor agents].
    Ninomiya K; Sekido S; Araki T
    Gan To Kagaku Ryoho; 1984 Jun; 11(6):1315-23. PubMed ID: 6428326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of actinomycin D or adriamycin antitumor activity with DNA.
    Marks TA; Venditti JM
    Cancer Res; 1976 Feb; 36(2 Pt 1):496-504. PubMed ID: 1260747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.